Viewing Study NCT03236857


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-02-24 @ 3:14 PM
Study NCT ID: NCT03236857
Status: COMPLETED
Last Update Posted: 2023-05-22
First Post: 2017-07-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module